GENE ONLINE|News &
Opinion
Blog

Ulcerative Colitis
Trials & Approvals Chronic Disease
The First and Only FDA-approved Drug for Chronic Digestive Diseases by Celltrion USA
2023-10-25
M&A MerckAutoimmune Disease
Merck Buys Prometheus For $10.8 Billion, Lands Promising Autoimmune Asset
2023-04-17
Trials & Approvals Bristol Myers Squibb
Bristol Myers Squibb’s Ulcerative Colitis Treatment Gains Further Validation
2022-10-25
M&A Ulcerative Colitis
Xbiome Acquires Ulcerative Colitis Program from Assembly Biosciences
2022-04-29
M&A PfizerUlcerative Colitis
Pfizer to Acquire Arena and its Immuno-Inflammatory Drug for $6.7 Billion
2021-12-14
Asia-Pacific Fecal Microbiota TransplantationAustralia
Australia’s BiomeBank Seeks Approval for the World’s First Microbial Therapy
2021-07-04
Trials & Approvals JAK1 Inhibitor
AbbVie’s JAK1 Inhibitor Aces Ulcerative Colitis Trial, Prospers Amid Tough Regulatory Climate
2021-07-02
Trials & Approvals Immutep
Immutep Announces Discontinuation of Phase 2 Ulcerative Colitis Study by GSK
2021-01-30
Trials & Approvals S1P
Bristol Myers Squibb’s Zeposia Shines in Ulcerative Colitis Trial
2020-10-13
Clostridium Difficile
Finch’s First Microbial Cocktail Treating Clostridium Infection Registers Positive Results
2020-06-24
M&A Anti-inflammatory Drugs
AbbVie Completes Acquisition of Botox Manufacturer, Allergan
2020-05-11
LATEST
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top